CUPID

Cupid Limited

Male and female condoms, lubricants, diagnostic kits and personal care products

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products›Personal Care

cupidlimited.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹353.70

Market cap

47,561 Cr

Stock P/E

346.2

P/B

105.50

Dividend yield

0.0%

ROE (FY26)

24.0%

ROCE (FY26)

29.0%

Operating margin (FY26)

31.2%

Debt / equity (FY26)

0.11

OCF / EBITDA (FY26)

39.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Cupid makes male and female condoms, water-based personal lubricants and in-vitro diagnostic (IVD) test kits, selling mainly to global health agencies, government tenders and private buyers in more than 125 countries, and is building a branded personal care range for Indian consumers.

Company snapshot

4thBy market cap

Ranked among 10 companies in Personal Care.

Segment mix

Reportable segments as of 2024-06-30 (Standalone). Revenue share = segment revenue ÷ total revenue.

Largest segment: 89.7% of revenue

Segment	Revenue share	Revenue	PBT	Assets
In Vitro Devices (IVD)	4.1%	2 Cr	0.21 Cr	11 Cr
Male and Female Contraceptives & Jelly	89.7%	35 Cr	6 Cr	113 Cr
Others / Unallocated	18.7%	7 Cr	4 Cr	212 Cr

Shares add up to 113% because segment revenues are before inter-segment eliminations.

What we see

Positives

✓Net margin of 30.3% — the business keeps a healthy share of every rupee it earns.

3 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Jun 2021	Sept 2021	Dec 2021	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	32 Cr	33 Cr	36 Cr	46 Cr	56 Cr	60 Cr	84 Cr	93 Cr	120 Cr	155 Cr
Operating expenses (approx.)	25 Cr	27 Cr	33 Cr	35 Cr	43 Cr	43 Cr	56 Cr	59 Cr	82 Cr	95 Cr
EBITDA	7 Cr	6 Cr	4 Cr	11 Cr	13 Cr	16 Cr	28 Cr	34 Cr	38 Cr	60 Cr
OPM %	22.7%	16.8%	9.9%	24.5%	23.7%	27.5%	33.6%	36.7%	31.3%	38.8%
Other income	1 Cr	1 Cr	0.76 Cr	4 Cr	5 Cr	5 Cr	6 Cr	11 Cr	12 Cr	2 Cr
Interest	0.02 Cr	0.04 Cr	0.04 Cr	0.41 Cr	0.78 Cr	0.62 Cr	0.70 Cr	0.61 Cr	0.87 Cr	1 Cr
Depreciation	0.61 Cr	0.61 Cr	0.62 Cr	1 Cr	1 Cr	1 Cr	1 Cr	1 Cr	1 Cr	1 Cr
Profit before tax	8 Cr	6 Cr	4 Cr	14 Cr	16 Cr	20 Cr	32 Cr	43 Cr	47 Cr	60 Cr
Tax %	24.9%	25.3%	33.7%	21.4%	28.0%	23.2%	25.0%	24.1%	23.6%	26.3%
Net profit	6 Cr	4 Cr	2 Cr	11 Cr	12 Cr	15 Cr	24 Cr	33 Cr	36 Cr	44 Cr
EPS (₹)	₹4.43	₹3.33	₹1.77	₹0.41	₹0.43	₹0.56	₹0.90	₹1.22	₹0.27	₹0.33

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2025	Mar 2026	TTM
Sales	184 Cr	358 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	142 Cr	241 Cr	Sign in free for the trailing twelve months
EBITDA	42 Cr	117 Cr	Sign in free for the trailing twelve months
OPM %	22.7%	32.6%	Sign in free for the trailing twelve months
Other income	20 Cr	34 Cr	Sign in free for the trailing twelve months
Interest	2 Cr	3 Cr	Sign in free for the trailing twelve months
Depreciation	4 Cr	5 Cr	Sign in free for the trailing twelve months
Profit before tax	55 Cr	142 Cr	Sign in free for the trailing twelve months
Tax %	25.5%	24.0%	Sign in free for the trailing twelve months
Net profit	41 Cr	108 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹1.52	₹0.81	Sign in free for the trailing twelve months
Dividend payout %	0.0%	0.0%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2025	Mar 2026
Equity capital	27 Cr	134 Cr
Reserves	315 Cr	316 Cr
Borrowings	13 Cr	51 Cr
Other liabilities	17 Cr	51 Cr
Total liabilities	372 Cr	553 Cr
Fixed assets (net)	67 Cr	67 Cr
CWIP	6 Cr	25 Cr
Investments	103 Cr	75 Cr
Loans & advances	0.49 Cr	0.05 Cr
Inventories	42 Cr	70 Cr
Trade receivables	67 Cr	101 Cr
Cash & bank	59 Cr	169 Cr
Other assets	28 Cr	47 Cr
Total assets	372 Cr	553 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2025	Mar 2026
Cash from operating activity	-11 Cr	46 Cr
Cash from investing	45 Cr	28 Cr
Cash from financing	-1 Cr	35 Cr
Net cash flow	32 Cr	110 Cr
Free cash flow (OCF − Capex)	-31 Cr	21 Cr

Ratios

Metric	Mar 2025	Mar 2026
ROCE %	16.0%	29.0%
ROE %	11.9%	24.0%
Debtor days	133	103
Inventory days	221	229
Days payable	7	100
Cash conversion cycle	348	232
OCF / EBITDA %	-27.2%	39.5%
Debt / equity	0.04	0.11
Current ratio	13.30	4.67
Net debt / EBITDA	-1.11	-1.01